Stroke Program Outcomes

Service:

View patient outcomes at our stroke receiving centers.

Stroke Program Outcomes at Long Beach Medical Center

Better outcomes, fewer complications for stroke patients

We invite you to view the outcomes performance related to stroke for the Comprehensive Stroke Center at Long Beach Medical Center.

Stroke Volume

The Comprehensive Stroke Center at Long Beach Medical Center treats nearly 1,000 stroke patients each year.

More than 60% of our patients go home or to a rehabilitation center after their stroke.

Stroke Volume All Diagnosis


 

Discharge Diagnosis Ischemic Stroke

Our tissue plasminogen activator (tPA) treatment times consistently meet the goals set by the American Stroke Association. Considered the gold standard, tPA is an FDA-approved treatment for ischemic strokes.

Discharge Diagnosis Ischemic Stroke

tPA Outcomes

Our tPA door-to-needle times are consistently great.

  • Goal is to administer tPA in under 60 minutes 75% of the time and\or administered in under 45 minutes 50% of the time.
  • Quarter 1 tPA administered under 60 minutes is 93%; Quarter 2 is 87%.
  • Quarter 1 tPA administered under 45 minutes 87%; Quarter 2 is 58%.
  • Our current tPA treatment rate is 20% when the national average is under 10%.
  • We have done tPA more than 50 times this year and have done more 30 thrombectomies.
     
  • Carotid Endarterectomy complication rate is only 3% when the national average is approximately 5%.

Committed to Quality

For eight consecutive years, the Comprehensive Stroke Center at Long Beach Medical Center has received the American Heart Association/American Stroke Association’s Get With The Guidelines®- Stroke Gold Plus Quality Achievement Award. The award recognizes Long Beach Medical Center’s commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.

Additionally, the Comprehensive Stroke Center received the association’s Target: StrokeSM Honor Roll award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.

Long Beach Medical Center also is a designated Joint Commission Certified Comprehensive Stroke Center. The Joint Commission offers four advanced levels of stroke certification for Joint Commission-accredited hospitals with the Comprehensive Stroke Center being the highest designation.

Get With The Guidelines 2018

Resources

American Stroke Association - About Stroke 

National Stroke Association - Learn More About Stroke

Stroke Program Outcomes at Saddleback Medical Center

Thrombectomy Patient Outcomes

Better outcomes, fewer complications for stroke patients

The Complications of Care trend graph displays the complications patients experienced at Saddleback Medical Center when treated with thrombectomy (removal of a clot in a vessel in the brain) for a stroke. It directly reflects both the hospital and physicians’ quality of care.

In the past rolling year, March 2017-February 2018, patients undergoing thrombectomy at Saddleback Medical Center did not experience any complications as a result of interventional treatment they received. In comparing patients who received a thrombectomy at Saddleback Medical Center to patients with similar medical diagnoses who received treatment at a hospital in the top 10% of mid-sized hospitals in the nation, month after month Saddleback Medical Center reported zero complications of care.

% Complications of Care - Laguna Hills

Re-admissions

The % 30 Day Re-admissions Measure (Any APR-DRG) displays the percentage of cases readmitted for any medical reason to the hospital within 30 days of undergoing a thrombectomy at Saddleback Medical Center. During the last rolling year, March 2017-February 2018, only one patient who received a thrombectomy was readmitted within 30 days of treatment. Saddleback’s 30 Day Readmission rate of 6.25% is far below the readmission rate experienced by the top 10% of hospitals caring for patients with similar medical diagnoses.


Saddleback’s 30 Day Readmission rate of 6.25%


2016 Get With The Guidelines - Stroke

2017 Get With The Guidelines - Stroke


American Heart Association - American Stroke Association